zanamivir has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chi, YM; Du, JF; Du, WX; Han, GC; Li, M; Liu, F | 1 |
| Pegram, PS; Williamson, JC | 1 |
| Wesseling, G | 1 |
2 review(s) available for zanamivir and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Neuraminidase inhibitors in patients with underlying airways disease.
Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir | 2002 |
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir | 2007 |
1 trial(s) available for zanamivir and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.
Topics: Antiviral Agents; Enzyme Inhibitors; Female; Humans; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Zanamivir | 2020 |